Vertex Pharmaceuticals Stock: Is Wall Street Bullish or Bearish?

Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology firm that discovers, develops, and commercializes transformative medicines for serious diseases, with a particular focus on treatments for cystic fibrosis and other genetic disorders. The company’s product portfolio includes several approved therapies, such as Trikafta/Kaftrio, and emerging drugs for conditions like sickle cell disease and acute pain, supported by a robust clinical pipeline across multiple therapeutic areas. Vertex is hea ...